Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ruff

Showing results (201-210 of 224) with videos related to

Pageof 23
Sort By:
Journal of the American College of Cardiology|September 3, 2025
Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation: Results in 18,000 Clinical Trial ParticipantsSean J Jurgens, Giorgio E M Melloni, Shinwan Kany, et al.
The New England Journal of Medicine|August 28, 2018
Cardiovascular Safety of Lorcaserin in Overweight or Obese PatientsErin A Bohula, Stephen D Wiviott, Darren K McGuire, et al.
JAMA Cardiology|February 28, 2024
Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic StenosisAeron M Small, Giorgio E M Melloni, Frederick K Kamanu, et al.
Journal of the American College of Cardiology|January 17, 2024
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art ReviewAntoine Bejjani, Candrika D Khairani, Ali Assi, et al.
The American Journal of Medicine|April 30, 2016
North American Thrombosis Forum, AF Action Initiative Consensus DocumentChristian T Ruff, Jack E Ansell, Richard C Becker, et al.
Lancet (London, England)|October 9, 2018
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trialErin A Bohula, Benjamin M Scirica, Silvio E Inzucchi, et al.
Circulation|August 30, 2025
Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart FailureDavid D Berg, Siddharth M Patel, Paul M Haller, et al.
Circulation|November 13, 2020
Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic DiseaseNicholas A Marston, Parth N Patel, Frederick K Kamanu, et al.
Circulation|August 29, 2022
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACTErin A Bohula, David D Berg, Mathew S Lopes, et al.
Circulation|January 5, 2022
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and SexAnthony P Carnicelli, Hwanhee Hong, Stuart J Connolly, et al.
Pageof 23

Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
Journal of the American College of Cardiology|September 3, 2025
Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation: Results in 18,000 Clinical Trial ParticipantsSean J Jurgens, Giorgio E M Melloni, Shinwan Kany, et al.
The New England Journal of Medicine|August 28, 2018
Cardiovascular Safety of Lorcaserin in Overweight or Obese PatientsErin A Bohula, Stephen D Wiviott, Darren K McGuire, et al.
JAMA Cardiology|February 28, 2024
Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic StenosisAeron M Small, Giorgio E M Melloni, Frederick K Kamanu, et al.
Journal of the American College of Cardiology|January 17, 2024
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art ReviewAntoine Bejjani, Candrika D Khairani, Ali Assi, et al.
The American Journal of Medicine|April 30, 2016
North American Thrombosis Forum, AF Action Initiative Consensus DocumentChristian T Ruff, Jack E Ansell, Richard C Becker, et al.
Lancet (London, England)|October 9, 2018
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trialErin A Bohula, Benjamin M Scirica, Silvio E Inzucchi, et al.
Circulation|August 30, 2025
Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart FailureDavid D Berg, Siddharth M Patel, Paul M Haller, et al.
Circulation|November 13, 2020
Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic DiseaseNicholas A Marston, Parth N Patel, Frederick K Kamanu, et al.
Circulation|August 29, 2022
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACTErin A Bohula, David D Berg, Mathew S Lopes, et al.
Circulation|January 5, 2022
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and SexAnthony P Carnicelli, Hwanhee Hong, Stuart J Connolly, et al.
Pageof 23